Drug Shortage Report for MYLAN-HYDROXYCHLOROQUINE

Last updated on 2018-07-05 History
Report ID 5925
Drug Identification Number 02252600
Brand name MYLAN-HYDROXYCHLOROQUINE
Common or Proper name HYDROXYCHLOROQUINE
Company Name MYLAN PHARMACEUTICALS ULC
Market Status CANCELLED POST MARKET
Active Ingredient(s) HYDROXYCHLOROQUINE SULFATE
Strength(s) 200MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100BT
ATC code P01BA
ATC description ANTIMALARIALS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2018-07-03
Actual start date 2018-07-03
Estimated end date Unknown
Actual end date 2018-07-03
Shortage status Resolved
Updated date 2018-07-05
Company comments Discontinued in ID 44856
Health Canada comments
Tier 3 Status No
Contact Address 85 ADVANCE ROAD
ETOBICOKE, ONTARIO
CANADA M8Z 2S6
Company contact information Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v25 2018-07-05 French Compare
v24 2018-07-05 English Compare
v23 2018-07-04 English Compare
v22 2018-07-03 French Compare
v21 2018-07-03 English Compare
v20 2018-04-04 French Compare
v19 2018-04-04 English Compare
v18 2017-12-01 English Compare
v17 2017-11-30 French Compare
v16 2017-11-30 English Compare
v15 2017-11-29 French Compare
v14 2017-11-29 English Compare
v13 2017-11-22 French Compare
v12 2017-11-22 English Compare
v11 2017-11-10 French Compare
v10 2017-11-10 English Compare
v9 2017-10-26 French Compare
v8 2017-10-26 English Compare
v7 2017-10-11 French Compare
v6 2017-10-11 English Compare

Showing 1 to 20 of 25